Clinical Trial Update: Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating thalidomide in combination with irinotecan for glioblastoma multiforme patients who have undergone prior radiation th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Camptosar (irinotecan)
• Thalomid (thalidomide)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED